Ahan Add-Chem Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.93 Cr
as on 17-12-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 36.40 Cr
as on 17-12-2024
- Revenue 158.15%
(FY 2021)
- Profit 45.72%
(FY 2021)
- Ebitda 42.27%
(FY 2021)
- Net Worth -53.09%
(FY 2021)
- Total Assets -5.76%
(FY 2021)
About Ahan Add-Chem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.93 Cr.
The company currently has active open charges totaling ₹36.40 Cr.
Rakesh Saraiya, Kamlesh Shah, and Venus Sanghvi serve as directors at the Company.
- CIN/LLPIN
U24100GJ2010PTC060139
- Company No.
060139
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ahan Add-Chem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venus Sanghvi  | Director | 04-Jan-2024 | Current |
| Rakesh Saraiya | Director | 03-Apr-2010 | Current |
| Kamlesh Shah | Director | 22-Jan-2016 | Current |
Financial Performance and Corporate Structure Insights of Ahan Add-Chem.
Ahan Add-Chem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 158.15% increase. The company also saw a substantial improvement in profitability, with a 45.72% increase in profit. The company's net worth observed a substantial decline by a decrease of 53.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ahan Add-Chem?
In 2021, Ahan Add-Chem had a promoter holding of 98.97% and a public holding of 1.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dr M L Dhawale Memorial Homeopathic InstituteActive 21 years 9 months
Kamlesh Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 15 Jul 2017 | ₹18.20 Cr | Open |
State Bank Of India Creation Date: 15 Jul 2017 | ₹18.20 Cr | Open |
How Many Employees Work at Ahan Add-Chem?
Ahan Add-Chem has a workforce of 11 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ahan Add-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ahan Add-Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
